LOGO
LOGO

Sixty Degrees' Survey Reveals Underreported Babesiosis Cases - A Growing Opportunity For ARAKODA?

By RTTNews Staff Writer   ✉  | Published:  | Google News Follow Us  | Join Us
rttnewslogo20mar2024

Sixty Degrees Pharmaceuticals Inc. (SXTP), Tuesday announced preliminary results from a nationwide survey indicating that the burden of babesiosis in the United States may be significantly higher than official statistics suggest, highlighting a potential unmet need for improved diagnosis and treatment options.

The company reported that 1.26 percent of surveyed U.S. adults—equivalent to approximately 3 million people—said they had been medically diagnosed with babesiosis in their lifetime.

Subscribe to continue reading the article.
This article is available exclusively to RTT Biotech Investor and Intelligent Investor subscribers. Subscribe with a RTTNews subscription.
Start Free Trial
FREE 7-Day Trial - No Payment Required
Already subscribed? Sign in

For comments and feedback contact: editorial@rttnews.com

Global Economics Weekly Update - Jun 08-12, 2026

June 12, 2026 17:14 ET
Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.

RELATED NEWS